A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU
Clinical trial NCT05485948 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05485948
- Sponsor
- PharmaEssentia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2022-09-07
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.